These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maintenance treatment for Crohn's disease: has the time arrived? Goldstein F Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706 [No Abstract] [Full Text] [Related]
3. The role of mesalazine in Crohn's disease. Hanauer SB Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296 [TBL] [Abstract][Full Text] [Related]
4. Maintenance of remission in Crohn's disease: is 5'-aminosalicylic acid the answer? Tremaine WJ Gastroenterology; 1992 Aug; 103(2):694-6. PubMed ID: 1353043 [No Abstract] [Full Text] [Related]
5. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Steinhart AH; Hemphill D; Greenberg GR Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225 [TBL] [Abstract][Full Text] [Related]
6. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE; Helmstädter V Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related]
7. Maintenance of symptomatic remission in patients with Crohn's disease. Stark ME; Tremaine WJ Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474 [TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease. van Hees PA Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723 [No Abstract] [Full Text] [Related]
9. [Prevention of recurrence of chronic inflammatory bowel diseases]. Dölle W; Hartmann F Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922 [No Abstract] [Full Text] [Related]
10. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis? Nakshabendi IM; Duncan A; Russell RI Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343 [TBL] [Abstract][Full Text] [Related]
11. [Current medical therapies for Crohn's disease in Japan]. Munakata A; Haga Y Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493 [TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
13. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid]. Peskar BM Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066 [No Abstract] [Full Text] [Related]
14. Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution? Sahmoud T; Mary JY; Sahmoud T Gut; 1997 Feb; 40(2):284-5. PubMed ID: 9071946 [No Abstract] [Full Text] [Related]
15. 5-Aminosalicylates for prevention of recurrence in patients with Crohn's disease: time for a reappraisal? Sutherland LR J Clin Gastroenterol; 1991 Feb; 13(1):5-7. PubMed ID: 2007746 [No Abstract] [Full Text] [Related]
16. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible? Rutgeerts P Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis. Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid]. Malchow H Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152 [No Abstract] [Full Text] [Related]
20. Will there be a next generation of sulfasalazine? Goldman P Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related] [Next] [New Search]